TNF and multiple sclerosis: Moreover, the negative patient outcomes with non-selective anti-TNF therapies (van Oosten et al., 1996; The Lenecercept Multiple Sclerosis Study Group, 1999) suggest that the complete abrogation of TNF signaling has no beneficial effects in MS.